TAK-755-4007: A Post-Authorization Safety Study (PASS) to Further Evaluate Real-World Safety in Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated with Adzynma

14/01/2026
16/03/2026
EU PAS number:
EUPAS1000000870
Study
Planned

ENCePP Code of conduct

No
Data sources

Data sources (types)

Electronic healthcare records (EHR)
Non-interventional study
Use of a Common Data Model (CDM)

CDM mapping

Yes

CDM Mappings

Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Yes